Sage Therapeutics Aktie

Kaufen
Verkaufen
7,95 EUR +0,05 EUR +0,68 %
8,29 USD -0,38 USD -4,33 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 469,92 Mio. EUR

Div. Rendite 0,00%

WKN A117WF

ISIN US78667J1088

Symbol SAGE


Sage Therapeutics Aktie Analyse

14.12.18 Sage Therapeutics Outperform Wolfe Research
11.10.18 Sage Therapeutics Outperform Oppenheimer & Co. Inc.
07.08.18 Sage Therapeutics Buy Stifel, Nicolaus & Co., Inc.
26.03.18 Sage Therapeutics Buy Canaccord Adams
08.12.17 Sage Therapeutics Buy Needham & Company, LLC
08.12.17 Sage Therapeutics Buy Canaccord Adams
07.12.17 Sage Therapeutics Buy Chardan Capital Markets
10.11.17 Sage Therapeutics Buy Needham & Company, LLC
10.11.17 Sage Therapeutics Buy Chardan Capital Markets
13.09.17 Sage Therapeutics Buy Needham & Company, LLC
09.08.17 Sage Therapeutics Buy Stifel, Nicolaus & Co., Inc.
16.05.17 Sage Therapeutics Buy Needham & Company, LLC
22.02.17 Sage Therapeutics Neutral H.C. Wainwright & Co.
14.02.17 Sage Therapeutics Neutral Chardan Capital Markets
14.11.16 Sage Therapeutics Buy Stifel, Nicolaus & Co., Inc.
13.07.16 Sage Therapeutics Buy Lake Street
23.06.16 Sage Therapeutics Buy H.C. Wainwright & Co.
24.05.16 Sage Therapeutics Sell Chardan Capital Markets
11.03.16 Sage Therapeutics Buy Lake Street
10.06.15 Sage Therapeutics Buy Canaccord Adams
21.05.15 Sage Therapeutics Buy Canaccord Adams
Werbung